UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

European heart journal, 2012-05, Vol.33 (9), p.1049-1057

2012

Volltextzugriff (PDF)

The Swedish CArdioPulmonary BioImage Study: objectives and design

Journal of internal medicine, 2015, Vol.278 (6), p.645-659

2015

Volltextzugriff (PDF)

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

The Lancet (British edition), 2005-09, Vol.366 (9489), p.895-906

2005

Volltextzugriff (PDF)

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

BMJ, 1996-05, Vol.312 (7041), p.1254-1259

International edition, 1996

Volltextzugriff (PDF)

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial

European heart journal, 2008-01, Vol.29 (2), p.166-176

2008

Volltextzugriff (PDF)

Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study

Diabetologia, 2011-06, Vol.54 (6), p.1308-1317

2011

Volltextzugriff (PDF)

The impact of serum uric acid on cardiovascular outcomes in the LIFE study

Kidney international, 2004-03, Vol.65 (3), p.1041-1049

2004

Volltextzugriff (PDF)

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

JAMA : the journal of the American Medical Association, 2004-11, Vol.292 (19), p.2343

2004

Volltextzugriff (PDF)

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The Lancet (British edition), 2005-09, Vol.366 (9489), p.907-913

2005

Volltextzugriff (PDF)

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

European heart journal, 2003-06, Vol.24 (11), p.987-1003

2003

Volltextzugriff (PDF)

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)

Diabetes care, 2005-05, Vol.28 (5), p.1151-1157

2005

Volltextzugriff (PDF)

Correction to: Serum heparan sulfate levels are elevated in endotoxemia

European journal of medical research, 2021-10, Vol.26 (1), p.1-126, Article 126

2021

Volltextzugriff (PDF)

The large‐scale placebo‐controlled beta‐blocker studies in systolic heart failure revisited: results from CIBIS‐II, COPERNICUS and SENIORS‐SHF compared with stratified subsets from MERIT‐HF

Journal of internal medicine, 2014-02, Vol.275 (2), p.134-143

2014

Volltextzugriff (PDF)

Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study

Journal of the American Society of Nephrology, 2001-02, Vol.12 (2), p.218-225

2001

Volltextzugriff (PDF)

Psychosocial factors and venous thromboembolism: a long‐term follow‐up study of Swedish men

Journal of thrombosis and haemostasis, 2008-04, Vol.6 (4), p.558-564

2008

Volltextzugriff (PDF)

Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial

European heart journal, 2006-12, Vol.27 (24), p.2982-2988

2006

Volltextzugriff (PDF)

The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial

European heart journal, 2013-02, Vol.34 (5), p.374-379

2013

Volltextzugriff (PDF)

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure

European heart journal, 2008-02, Vol.29 (4), p.499-508

2008

Volltextzugriff (PDF)

Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the β-blocker cholesterol-lowering asymptomatic plaque study (BCAPS)

Circulation (New York, N.Y.), 2001-04, Vol.103 (13), p.1721-1726

2001

Volltextzugriff (PDF)

Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial

Heart (British Cardiac Society), 2009-05, Vol.95 (9), p.721-727

2009

Volltextzugriff (PDF)

Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study

Diabetic medicine, 2012-12, Vol.29 (12), p.1501-1505

2012

Volltextzugriff (PDF)

Estrogenic personal care products in a greywater reuse system

Water science and technology, 2007-01, Vol.56 (12), p.45-49

2007

Volltextzugriff (PDF)

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristics

European journal of heart failure, 2005-10, Vol.7 (6), p.1059-1069

2005

Volltextzugriff (PDF)

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

Journal of the American College of Cardiology, 1995-07, Vol.26 (1), p.57-65

1995

Volltextzugriff (PDF)

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? : Experiences from the metoprolol controlled release/extended release randomized intervention trial in chronic heart failure (MERIT-HF)

Journal of the American College of Cardiology, 2005-01, Vol.45 (2), p.252-259

2005

Volltextzugriff (PDF)

1 – 25 von 1.104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(926)
Mit Volltextzugriff
(846)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(544)
Humans
(527)
Life Sciences & Biomedicine
(498)
Male
(351)
Female
(300)
Middle Aged
(275)
Biological And Medical Sciences
(270)
Medical Sciences
(250)
Aged
(228)
Adult
(188)
Medicin Och Hälsovetenskap
(125)
Cardiovascular System & Cardiology
(119)
General & Internal Medicine
(103)
Risk Factors
(94)
Medicine, General & Internal
(91)
Animals
(85)
Cardiac & Cardiovascular Systems
(82)
Aged, 80 And Over
(74)
Mortality
(74)
Pharmacology. Drug Treatments
(73)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

The Swedish CArdioPulmonary BioImage Study: objectives and design

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial

Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study

The impact of serum uric acid on cardiovascular outcomes in the LIFE study

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)

Correction to: Serum heparan sulfate levels are elevated in endotoxemia

The large‐scale placebo‐controlled beta‐blocker studies in systolic heart failure revisited: results from CIBIS‐II, COPERNICUS and SENIORS‐SHF compared with stratified subsets from MERIT‐HF

Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study

Psychosocial factors and venous thromboembolism: a long‐term follow‐up study of Swedish men

Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial

The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure

Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the β-blocker cholesterol-lowering asymptomatic plaque study (BCAPS)

Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial

Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study

Estrogenic personal care products in a greywater reuse system

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristics

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? : Experiences from the metoprolol controlled release/extended release randomized intervention trial in chronic heart failure (MERIT-HF)

Suchergebnisse filtern